Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany

ABSTRACT:

SUBMITTER: Bidlingmaier C 

PROVIDER: S-EPMC11295478 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature